STIM — Neuronetics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Neuronetics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	75.7	49	94.1	70.3	59.7
Net Total Accounts Receivable
Net Total Receivables	7.45	9.05	9.98	15.4	18.7
Total Inventory
Prepaid Expenses
Total Current Assets	88.5	65	115	98.8	93.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.9	5.35	5.1	5.32	4.78
Long Term Notes Receivable
Other Long Term Assets
Total Assets	100	78.7	141	117	116
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	27.7	13.7	15.7	33.2	19.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	52.3	53.2	56	59.8	81.6
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	47.9	25.5	85.2	57.1	34.2
Total Liabilities & Shareholders' Equity	100	78.7	141	117	116
Total Common Shares Outstanding